经济学人浓咖啡马拉松计划doing！第-79天。
J&J to break up; as is Toshiba
强生、东芝宣布拆分
Johnson & Johnson, the world’s largest health-care company^1 by sales,
announced plans to separate its consumer-health division^2 into another
publicly traded firm in the next two years.
强生是全球销售额最大的医疗保健公司，它宣布计划在两年内把消费品部门拆分成一个新的上市公司。
The lower-margin unit—maker of Tylenol, Band-Aid bandages and Neutrogena beauty
products—generates $15bn in revenues a year, compared with the pharmaceutical
arm^3’s $77bn.
和制药部门770亿美元的年收入相比，消费品部门的利润低得多—泰诺液体制剂、Band-Aid绷带和露得清护肤产品带来的年收入仅150亿美元。
Other health-care firms, such as GSK, Merck and Pfizer, have shed^4 their
consumer-health divisions in recent years
其他医疗保健公司诸如葛兰素史克、默沙东、辉瑞，近几年已经剥离了消费品部门。
Corporate breakups are clearly in fashion, as a special committee at Toshiba
presented a plan to split the Japanese conglomerate^5 into three parts.
东芝董事会战略审查委员会宣布了将其企业集团拆分为3个独立公司的计划，可见公司的拆分几乎成为潮流。
The decision, emerging from a five-month review, comes on the heels of General
Electric’s own tripartite split^6.
继通用电气宣布一分为三之后，东芝经5个月的审查后也公布了这项决定。
If approved, its energy and device-making businesses would become offshoots^7.
如果通过审批，能源系统和电子设备制造业务将成为单独的分支。
Toshiba’s board had been weighing the option of^8 taking the whole company
private, but angry shareholders dissuaded^9 them.
此前，东芝的董事会曾考虑把整个公司私有化，这惹怒了股东，并遭到劝阻。
最早接触到强生就是强生婴儿沐浴露了，后来才知道强生的主打是医疗保健。这些大企业做业务拆分，说明了专精才是王道，竞争还得用长板。
